Achievements in the control of acute respiratory infection (ARI) owe much to international collaboration in research, education, and delivery of services. This article highlights some of the current activities of the many international agencies involved and summarizes thoughts on their future roles. Key recent scientific advances include better surveillance, new and improved vaccines, refinement of standard clinical management plans and behavioral change techniques, and demonstration of the effectiveness of their application. Agencies involved include the World Health Organization, the International Union Against Tuberculosis and Lung Disease, national government agencies for overseas aid, many academic departments, and professional lung health associations. However, much remains to be done, especially in collaborative research, in the devising, implementing, and evaluating of health care delivery systems in low-income countries, and in mobilizing political will and resources. These are tasks beyond the capacity of any lone agency. Success will depend on how effectively we collaborate.
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At the end of the acute respiratory infection (ARI) conferthe ARI problem in terms of morbidity and mortality in many countries that previously had little or no available information. ence in Sydney in 1984, I concluded by reminding colleagues that ARI control will be achieved only by teamwork at national This provides an essential baseline against which progress can be assessed and serves to guide future policies and priorities. and international levels. This remained emphatically true in 1997. A hugely important dividend of the 1984 conference was One continuing deficiency, however, is the lack of techniques needed for the rapid and reliable identification and characterizathat it helped to map out the problems and clarify how each of us, individually and through the national and international tion of etiological agents, both bacterial and viral. Definitive agencies with which we are associated, could contribute most knowledge of these is essential both to guide treatment and to effectively to the global effort. Now we have been able to monitor changes in resistance to antibiotics and the prevalence stand back and take stock of progress, review relevant scientific of types of organisms. advances, and reappraise contemporary needs and opportuniStandard clinical management regimens, which were in their ties. This done, we must now refocus our efforts to match the infancy in 1984, have been refined and tested in the cauldron new perspectives. My main aim, then, in this brief article is to of primary care and in the demanding circumstances of remote suggest where our future activities need to be focused. the development and trials of vaccines, especially the promising pneumococcal conjugate vaccines; research into the use of antibiotics in ARI and the problems of resistance; the reduction of Activities of International Agencies indoor air pollution through the introduction of cleaner household energy sources; and the production and testing of IMCI Until the late 1970s, there was little appreciation of the size of the problem of ARI, and no attention was paid to it by any training materials. The WHO is now vigorously promoting IMCI as the most effective strategy for reducing childhood of the major international agencies. Then the World Health Organization (WHO) and the International Union Against Tumortality related to ARI as well as other causes, and is keen to encourage partner agencies to pick up this theme. It also berculosis and Lung Diseases (IUATLD) both began to take an interest. Both recruited the assistance and collaboration of looks to partners for long-term support for research and development, and particularly for help with training and program others, including funding from several national overseas development agencies and lung health associations and research inimplementation. put from academic institutions. This established a momentum that has proved both exciting and productive.
International Union Against Tuberculosis and Lung Diseases
The IUATLD is, of course, best known for its distinguished World Health Organization record in the fight against tuberculosis. It is less well known that since the late 1970s the union has expanded its area of The WHO Programme for ARI was formally launched in 1984. Since then there has been an impressive program of work and interest to other lung diseases and the promotion of lung health more generally. This includes work on asthma, research and development. Initially, efforts were concentrated on the construction of simplified case-management protocols.
occupational lung disease, ARIs, and the fight against tobacco. It is the only large international organization other than the In the ensuing years there has been extensive work on validation of the most discriminating and readily recognized clinical WHO engaged in such a range of work, and I believe that its activities and commitment in this field deserve to be better signs of pneumonia; on the pharmacokinetics of antibiotic therapy; on alternative treatment regimens; on the surveillance of known.
The aims of the IUATLD are the prevention and control antibiotic resistance; on the place of oxygen therapy and on the techniques of oxygen concentration and economical delivof tuberculosis and the promotion of lung health and related community health, with particular focus on the priority probery; and into the special problems of the management of ARI in very young and malnourished infants.
lems of low-income countries. It pursues its aims through research, education, and technical assistance. An important later innovation was the development of the technique of ''focused ethnographic study,'' whereby socialResearch. Projects are sponsored and coordinated largely through its five scientific sections and their working groups. cultural data on the factors that influence caretaker behavior were obtained. These data helped to improve the local relevance
The respiratory section activities currently include working groups on model ARI program development; surveillance of of the content and language of advice related to home care and prevention of ARI. Alongside all of this, a program of training and response to ARI drug resistance; research training courses; and asthma management in low-income countries. The section for managers and caregivers was instituted, and a series of technical documents and practical guides and training materials has also promoted the creation of a research database that provides an inventory of current research in the field of ARI was produced both for local health workers and for the education of mothers in the home management of ARI. and plans to expand the newly created Annik Rouillon Documentation Centre to provide a literature resource and informaRecently, attention has turned to the evaluation of alternative preventive interventions. The aim was to identify the most tion facility for lung disease as well as for tuberculosis. Education and training. Funding agencies interested in effective, feasible, and affordable interventions to prevent childhood pneumonia. Available data were used to construct supporting operational research on lung health services in lowincome countries have reported disappointment at the poor models to assess the potential impact of different interventions. These have identified vaccines, indoor air pollution, and nutriquality of many project proposals, which they attribute to a lack of training in research methods. The IUATLD has a long tional factors as particularly important.
In the last few years, the WHO strategy has switched from history of providing international training courses in tuberculosis research and program management focused on the needs of promoting a series of vertical child health programs, of which the ARI program was one, to the concept of integrated managelow-income countries. It was well-placed, therefore, to take an / 9c61$$fe35 01-19-99 13:45:07 cidas UC: CID Miller CID 1999; 28 (February) initiative to meet this need. Training based in developed-counHowever, while the funding was mandatory to underpin the core work, equally important have been the largely unpaid try institutions is now widely considered to be inappropriate. The IUATLD, in partnership with other international agencies contributions of numerous academic institutions and individuals in both developed and developing countries around the and academic institutions, has therefore assembled teams of experienced academics who run short, repetitive courses in world who have provided essential expertise and research endeavors. The channels for such work have been many and epidemiological research methods and strategies for the prevention of lung disease and the promotion of lung health in various varied. Some were by direct input into the programs of the international agencies and others through bilateral or multilatregions of the world. The aim is to create a local cadre of research-competent clinical and public health collaborators caeral ad hoc collaboration. The common ingredients of all these efforts have been hard work and selfless commitment to collabpable of sustaining training programs and conducting research projects, thereby strengthening local capacity to plan and imoration. plement effective lung health programs.
Other educational activities include dissemination of inforFuture Roles for International Collaboration mation, exchange of expertise and experience, and stimulating scientific inquiry through conferences, publications, and scien-
The priorities for the future are to a large extent ''more of the same'' of what has been so productive in the past decade. tific statements. It publishes the International Journal of Tuberculosis and Lung Disease and is keen to encourage ARI reHowever, contributors to this conference have identified the need for significant shifts in emphasis as well as for new work searchers to submit their work for publication in the journal, especially on issues related to service provision and public related to new technologies and changes in the nature of the problem. As ever, there is a need for strong partnerships behealth.
Technical assistance. The IUATLD has extensive experitween developed and developing countries, between funding bodies and academic researchers, between teachers and operaence in assisting low-income countries in the design and delivery of programs for tuberculosis control. It makes sense to tional agencies, and between managers and those who deliver services in the field. We should look to them individually and build on this experience and to take advantage of the strong network of individual members and member associations in corporately, in particular (1) ensure that we have in place systems that will provide a continuous flow of high-quality informost such countries to undertake similar services in relation to ARI control. Some of the recommended features of control mation on mortality and morbidity rates in target populations and on the prevalence of causal organisms and of antibiotic programs are too costly to be practical in many countries, and it is essential to strip these down to the bare essentials and resistance; (2) promote research into improved vaccines, treatments, and diagnostic technologies and to give high priority to assist in shaping precisely focused action at the district hospital level, with the primary objective of saving lives and avoiding trials of new products and alternative regimens; (3) collaborate in the production of high-quality educational materials that are inappropriate antibiotic use. To assist in this work, the IUATLD has recently produced simple guides for the management of locally and culturally appropriate; (4) promote intersectoral action related to environmental interventions that have been asthma and of cough or difficult breathing in children. Both guides will now be subject to operational trials.
shown to be effective; (5) conduct operational studies into the most cost-effective ways of providing services within the constraints of local resources; (6) provide training in research methods and in the management and delivery of effective pre-
Other Agencies
ventive and treatment services within the context of local circumstances; (7) provide assistance and advice on realistic proOf course, none of the work described above could have been successfully prosecuted without the support and collabogram implementation in countries with the highest child mortality rate related to ARI; and (8) help mobilize support ration of a large number of other agencies and individuals. There has been generous financial aid for research, training, for ARI programs among the health professions, administrators, politicians, and the public, including parents, community leadand program development provided by a range of public and private funding bodies, including national governments through ers, and health care workers at all levels. their contributions to the WHO and United Nations Children's Fund (UNICEF), and in other ways, outstandingly through U.S. Conclusion Agency for International Development (USAID), the Canadian International Development Research Center, the British InterWhen we met in Sydney in 1984, at the conclusion of that seminal event, I reminded the audience that 90,000 children national Development Department, the Australian Agency for International Development (AusAID), and the member associahad died of ARI while we had been talking about how to save them. Despite the efforts of the intervening years, while there tions of IUATLD and of other organizations such as Save the Children Fund.
has been some progress, ARI remains the biggest killer of / 9c61$$fe35 01-19-99 13:45:07 cidas UC: CID young children around the world. We have heard that the main that the appalling toll of ARI among the world's children is brought low. The technology we most lack is in simple, effecreason for this is our failure to deliver potentially life-saving interventions where they are most needed, which we know tive, and efficient health care delivery systems appropriate to poor economies and difficult terrains, yet this was the object could be effective if properly applied. We cannot allow ourselves the luxury of complacency induced by the limited sucof research least often mentioned at this conference. The challenge we face is to work together to remedy this deficiency, cess achieved to date while this scandal persists.
It is clear from the presentations at this conference that we to mobilize the necessary resources, and to accord appropriate priority to implementing the feasible and effective interventions have between us, individually and in the international agencies with which many of us are associated, the experience, the skills, that are already available to us. In 1984, we were poised to advance. Now we must bend all our efforts to win! the knowledge, and most of the technology required to ensure / 9c61$$fe35 01-19-99 13:45:07 cidas UC: CID
